Boston Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-860,699
Closed -$16.3M 745
2024
Q3
$16.3M Sell
860,699
-123,739
-13% -$2.56M 0.02% 353
2024
Q2
$20.5M Sell
984,438
-44,307
-4% -$881K 0.03% 326
2024
Q1
$19.3M Buy
+1,028,745
New +$17.7M 0.02% 331

Other funds holding OGN

Boston Partners's OGN Position: Q4 2024 in Review

Boston Partners sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 860,699 shares — an estimated $16.3M sold.

Boston Partners first reported a position in OGN in Q1 2024 and held it in 3 quarters. The position peaked at $20.5M in Q2 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Boston Partners reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Boston Partners sold 860,699 Organon & Co shares in Q4 2024, an estimated $16.3M.
  • Boston Partners first reported a position in Organon & Co in Q1 2024 and held it in 3 quarters.
  • Boston Partners's Organon & Co position peaked at $20.5M in Q2 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Boston Partners's 13F filing for Q4 2024, filed 11 Feb 2025.